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The complete amino acid sequence of the porcine cardiac muscarinic acetylcholine receptor has been de- 
duced by cloning and sequencing the cDNA. The tissue location of the RNA hybridizing with the cDNA 
suggests hat this muscarinic receptor species represents the M2 subtype. 
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1. INTRODUCTION 
The muscarinic acetylcholine receptor (mAChR) 
mediates various cellular responses through the ac- 
tion of guanine nucleotide-binding regulatory pro- 
teins (G-proteins) [l-3]. Pharmacologically dis- 
tinguishable subtypes of the mAChR occur in dif- 
ferent tissues and have provisionally been 
classified into Mr and MZ subtypes on the basis of 
their difference in apparent affinity for the an- 
tagonist pirenzepine [4-61. We have previously 
isolated DNA complementary to porcine cerebral 
mRNA encoding mAChR and have deduced the 
primary structure of the receptor protein from the 
nucleotide sequence of the cDNA [7]. The tissue 
location of the mRNA, in conjunction with the 
high apparent affinity for pirenzepine of the 
mAChR expressed from the cDNA, has led to the 
Abbreviation: mAChR, muscarinic acetylcholine 
ceptor 
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re- 
proposition that this protein is the mAChR of the 
Mr subtype [7]. In the present investigation, we 
have cloned andi sequenced cDNA encoding 
another species of porcine mAChR and have thus 
deduced the complete amino acid sequence of the 
protein. The preferential location of the RNA 
hybridizing with the cDNA in the heart and 
medulla-pons suggests that this mAChR species 
represents the MZ subtype. 
2. MATERIALS AND METHODS 
Total RNA was extracted from porcine tissues 
P31, and poly(A)+ RNA isolated as in [9]. 
Oligodeoxyribonucleotides were synthesized by the 
triester method [lo], except that the primer 
5 ’ -AGAGGATGAAGGAGAGG-3 ’ was prepared 
with an automatic DNA synthesizer (Applied 
Biosystems). The procedures used to clone 
transcripts formed by extension of a synthetic 
primer into the PstI site of the plasmid pBR322 
have been described previously [ 1 I]. Escherichiu 
coli HBlOl or MC1061 was used for transforma- 
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tion [ 121. Transformants were screened [131, using 
a hybridization probe labelled with 32P at the 
5 ’ -end. For constructing the Okayama-Berg 
cDNA library [ 141, 15.6 pg of porcine atria1 
poly(A)+ RNA and 4.2 fig of the vector-primer 
DNA were used; the hybridization probe used to 
screen this library was labelled by nick-translation 
[15] with [a-32P]dCTP. DNA sequencing was car- 
ried out according to [16]. RNA blot hybridization 
analysis was performed as in [7]. 
3. RESULTS AND DISCUSSION 
In our previous study [7], the mAChR, purified 
from porcine cerebrum [ 171, was digested with 
trypsin, and the resulting peptides were frac- 
tionated by reverse-phase high-performance liquid 
chromatography. The amino acid sequences deter- 
mined for peptide fractions corresponding to 
relatively large absorbance peaks (fractions I, II 
and III) were found to be encoded by the porcine 
cerebral mAChR cDNA isolated. However, 
analysis of peptide fractions corresponding to 
minor absorbance peaks disclosed that their amino 
acid sequences were not included in the sequence 
predicted from the cDNA. These were the se- 
quences EPVANQEPVSPXLVQG and DDEIT- 
QDENTVXXSL (in one-letter code) determined 
from fraction IV (eluted at 3 1.8 min) and fraction 
V (eluted at 34.7 min), respectively, which were 
collected in the experiment shown in fig. 1A in [7]. 
This finding raised the question of whether the 
tryptic peptides IV and V are derived from a dif- 
ferent mAChR protein. An attempt was therefore 
made to clone cDNA encoding a second mAChR 
species. 
The synthetic oligodeoxyribonucleotide primer 
5 ’ -GT$TTETC&TCzTG-3 ’ , corresponding to the 
partial sequence QDENT of peptide V, was ex- 
tended by reverse transcriptase using porcine 
cerebral poly(A)+ RNA as template. The resulting 
single-stranded cDNA was converted to double- 
stranded cDNA, which was cloned in the plasmid 
pBR322. These clones were screened by hybridiza- 
tion at 36°C with the synthetic oligodeoxyribo- 
nucleotide probe A 
nucleotide probe 5 ’ -GTTAT$TCkTCi$TC-3 ’ cor- 
G 
responding to the amino-terminal sequence 
DDEIT of peptide V. Thus, two clones were 
368 
isolated from - 6.7 x lo5 transformants. Nucleo- 
tide sequence analysis of one of these clones 
(pmACR423) revealed that it carried a 596-base- 
pair cDNA insert including the sequences that en- 
code the amino acid sequences determined for pep- 
tides IV and V in the same reading frame. 
Because RNA blot hybridization analysis in- 
dicated that porcine atrium contained a relatively 
large amount of RNA hybridizable with a cDNA 
probe derived from pmACR423, a library of 
cDNA clones was constructed using poly(A)+ 
RNA from this tissue and the Okayama-Berg vec- 
tor [14]. Screening of this library (-2.4x lo5 
transformants) by hybridization at 60°C with the 
MnfI(337)-DdeI(813) fragment (numbers indi- 
cating the 5 ‘-terminal nucleotide generated by 
cleavage; for nucleotide numbers, see fig.1) de- 
rived from pmACR423 yielded one positive clone 
(phmACRlS), which harboured a - 3-kilobase- 
pair cDNA insert. 
Because the cDNA sequence carried by 
pmACR423 did not extend to the translational in- 
itiation site, the synthetic oligodeoxyribonucleo- 
tide primer 5 ’ -AGAGGATGAAGGAGAGG-3 ’ , 
which is complementary to the sequence of 
nucleotide residues 447-463 in pmACR423, was 
extended using porcine atria1 poly(A)+ RNA as 
template and then cloned in the plasmid pBR322 as 
described above. Screening of these clones 
(- 1.2 x lo5 transformants) by hybridization at 
50°C with the HinfI(337)-AvaII(405) fragment 
from pmACR423 yielded five positive clones. 
Nucleotide sequence analysis of one of them 
(phmACR905) showed that it carried a 589-base- 
pair cDNA sequence, which extended beyond the 
translational initiation site. 
Fig. 1 shows the 1665-nucleotide cDNA sequence 
determined with clones phmACR905, pmACR423 
and phmACR15. The reading frame corre- 
sponding to the amino acid sequences determined 
for the tryptic peptides IV and V (amino acid 
residues 223-238 and 298-312) was used to deduce 
the primary structure of the protein encoded by 
this cDNA (referred to hereafter as the cardiac 
mAChR). The translational initiation site was 
assigned to the methionine codon composed of 
nucleotide residues l-3 because this is the first 
ATG triplet that appears downstream of a 
nonsense codon, TAG (nucleotide residues - 108 
to - 106), found in frame. A translational ter- 
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5'-----CGAAGG -121 
10 20 30 
Me: Asn Asn Ser Thr Asn Ser Ser Asn Ser Gly Leu Ala Leu Thr Ser Pro Tyr Lys Thr Phe Glu Val Val Phe Ile Val Leu Val Ala 
ATG AAT AAC TCC ACC AAC TCC TCT AAC AGT GGC CTG GCT CTG ACC AGT CCT TAT AAG ACA TTT GAA GTG GTT TTT ATT GTC CTT GTC GCC 90 
40 50 60 
Gly Ser Leu Ser Leu Val Thr Ile Ile Gly Asn Ile Leu Val Met Val Ser Ile Lys Val Asn At-9 His Leu Gln Thr Val Asn Asn Tyr 
GGA TCC CTC AGT TTG GTG ACC ATT ATT GGG AAC ATC CTG GTC ATG GTC TCC ATC AAA GTC AAC CGA CAC CTC CAG ACA GTC AAC AAT TAC 180 
70 80 90 
Phe Leu Phe Ser Leu Ala Cys Ala Asp Leu Ile Ile Gly Val Phe Ser Met Asn Leu Tyr Thr Leu Tyr Thr Val Ile Gly Tyr Trp Pro 
TTT TTG TTC AGC TTG GCC TGT GCT GAC CTC ATC ATT GGT GTT TTC TCC ATG AAC CTG TAC ACT CTT TAC ACT GTG ATT GGC TAC TGG CCT 270 
100 110 120 
Leu Gly Pro Val Val Cys Asp Leu Trp Leu Ala Leu Asp Tyr Val Val Ser Asn Ala Ser Val Met Asn Leu Leu Ile Ile Ser Phe Asp 
TTG GGC CCC GTG GTG TGT GAC CTT TGG CTA GCT CTG GAC TAC GTG GTC AGT AAT GCC TCA GTA ATG AAT CTG CTC ATC ATC AGC TTT GAC 360 
130 140 150 
Arg Tyr Phe Cys Val Thr Lys Pro Leu Thr Tyr Pro Val Lys Arg Thr Thr Lys Met Ala Gly Met Met Ile Ala Ala Ala Trp Val Leu 
AGG TAC TTC TGT GTC ACG AAG CCG CTC ACC TAC CCC GTC AAG CGG ACC ACA AAA ATG GCA GGT ATG ATG ATT GCT GCT GCG TGG GTC CTC 450 
160 170 180 
Ser Phe Ile Leu Trp Ala Pro Ala Ile Leu Phe Trp Gln Phe Ile Val Gly Val Arg Thr Val Glu Asp Gly Glu Cys Tyr Ile Gln Phe 
TCC TTC ATC CTC TGG GCT CCG GCC ATT CTC TTC TGG CAG TTC ATT GTA GGG GTG AGA ACT GTG GAG GAT GGT GAA TGC TAT ATA CAG TTT 540 
I90 200 210 
Phe Ser Asn Ala Ala Val Thr Phe Gly Thr Ala Ile Ala Ala Phe Tyr Leu Pro Val Ile Ile Met Thr Val Leu Tyr Trp His Ile Ser 
TTT TCC AAC GCT GCT GTC ACC TTT GGC ACT GCC ATT GCA GCC TTC TAT TTG CCT GTG ATC ATC ATG ACT GTA TTA TAC TGG CAC ATA TCC 630 
220 230 240 
Arg Ala Ser Lys Ser Arg Ile Lys Lys Asp Lys Lys Glu Pro Val Ala Asn Gln Glu Pro Val Ser Pro Ser Leu Val Gln Gly Arg Ile 
CGA GCC AGT AAG AGC AGG ATT AAG AAG GAC AAG AAG GAG CCT GTG GCC AAC CAA GAA CCA GTT TCT CCA AGT TTG GTA CAA GGA AGA ATA 720 
250 260 Ser 270 
Val Lys Pro Asn Asn Asn Asn Met Pro Gly Ser Asp Glu Ala Leu Glu His Asn Lys Ile Gln Asn Gly Lys Ala Pro Arg Asp Ala Val 
GTG AAG CCG AAC AAC AAT AAT ATG CCT GGC AGT GAT GAA GCC CTG GAG CAC AAC AAA ATC CAG AAT GGC AAA GCT CCC AGG GAT GCT GTG 810 
280 290 A 300 
Thr Glu Asn Cys Val Gln Gly Glu Glu Lys Glu Ser Ser Asn Asp Ser‘Thr Ser Val Ser Ala Val Ala Ser Asn Met Arg Asp Asp Glu 
ACT GAG AAC TGT GTC CAG GGA GAG GAG AAA GAA AGC TCC AAC GAT TCC ACC TCA GTC AGT GCT GTT GCC TCT AAT ATG AGA GAT GAT GAA 900 
310 320 330 
Ile Thr Gln Asp Glu Asn Thr Val Ser Thr Ser Leu Gly His Ser Lys Asp Glu Asn Ser Lys Gln Thr Cys Ile Lys Ile Val Thr Lys 
ATA ACC CAG GAT GAA AAC ACA GTT TCC ACT TCC CTG GGC CAT TCC AAA GAT GAG AAC TCA AAG CAA ACA TGC ATC AAA ATT GTC ACC AAG 990 
340 350 360 
Thr Gln Lys Ser Asp Ser Cys Thr Pro Ala Asn Thr Thr Val Glu Leu Val Gly Ser Ser Gly Gln Asn Gly Asp Glu Lys Gln Asn Ile 
ACC CAA AAA AGT GAC TCA TGC ACC CCA GCT AAT ACC ACT GTG GAG CTT GTT GGT TCT TCA GGT CAG AAT GGA GAT GAA AAA CAG AAC ATT 1080 
370 380 390 
Val Ala Arg Lys Ile Val Lys Met Thr Lys Gln Pro Ala Lys Lys Lys Pro Pro Pro Ser Arg Glu Lys Lys Val Thr Arg Thr Ile Leu 
GTC GCT CGC AAG ATT GTG AAG ATG ACC AAG CAG CCT GCA AAA AAG AAG CCG CCT CCT TCC CGG GAA AAG AAA GTG ACC AGG ACG ATC TTG 1170 
400 410 420 
Ala Ile Leu Leu Ala Phe Ile Ile Thr Trp Ala Pro Tyr Asn Val Met Val Leu Ile Asn Thr Phe Cys Ala Pro Cys Ile Pro Asn Thr 
GCT ATT CTG TTG GCT TTC ATC ATC ACT TGG GCC CCG TAC AAC GTC ATG GTG CTC ATT AAT ACC TTC TGT GCA CCC TGC ATC CCC AAC ACA 1260 
430 440 450 
Val Trp Thr Ile Gly Tyr Trp Leu Cys Tyr Ile Asn Ser Thr Ile Asn Pro Ala Cys Tyr Ala Leu Cys Asn Ala Thr Phe Lys Lys Thr 
GTG TGG ACA ATT GGT TAT TGG CTC TGT TAC ATC AAC AGC ACT ATC AAC CCT GCC TGC TAT GCA CTT TGT AAT GCC ACC TTC AAG AAG ACC 1350 
460 
Phe Lys HIS Leu Leu Met Cys His Tyr Lys Asn Ile Gly Ala Thr Arg 
TTT AAA CAC CTT CTT ATG TGT CAT TAT AAG AAC ATA GGC GCT ACA AGG TAA AACATCTTTGTAAAGAAGGAAGGTAGTCAAGAGGAGCTTGAGGAACAGAAAA 1453 
AGAATGAAAGAGCTCCTAGTTTTAAAATCTCTGCCATTGCACTTTATAGTCTTATT~TGG~TGTGCAATTAAGGAGCCCTACAG-----3~ 
Fig. 1. Nucleotide sequence of the cDNA encoding the porcine cardiac mAChR. The nucleotide sequence was determined 
using clones phmACR905 (nucleotides - 126 to 463), pmACR423 (nucleotides 324-919) and phmACR15 (nucleotides 
756-1539); the 3’-terminal - 2-kilobase-pair cDNA sequence of phmACR15 was not determined. Nucleotide residues 
are numbered in the 5’- to 3’-direction, beginning with the first residue of the ATG triplet encoding the initiating 
methionine, and the nucleotides on the 5 ‘-side of residue 1 are indicated by negative numbers; the number of the 
nucleotide residue at the right end of each line is given. The deduced amino acid sequence of the porcine cardiac mAChR 
is shown above the nucleotide sequence, and amino acid residues are numbered beginning with the initiating methionine. 
Neither the 5 ’ - nor the 3 ’ -noncoding sequence presented is complete. A difference in nucleotide residue 787 is observed 
between clones phmACR15 (G) and pmACR423 (A), resulting in replacement of Gly by Ser (residue 263). 
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mination codon (TAA) occurs in frame after the 
466th codon specifying arginine. Thus, the cardiac 
mAChR consists of 466 amino acid residues (in- 
cluding the initiating methionine) and has a 
calculated M, of 51670, which agrees with the 
reported M, of the protein moiety of the porcine 
cardiac mAChR [ 181. 
Fig.2 shows the alignment of the amino acid se- 
quences of the cardiac and cerebral mAChRs. The 
two sequences are highly homologous, except that 
amino acid residues 219-370 of the cardiac 
mAChR and residues 221-347 of the cerebral 
mAChR showed no apparent sequence homology. 
Of the positions aligned, 60% are occupied by 
identical residues and 22% by conservative 
residues. In general, the putative transmembrane 
segments (see below) are better conserved. It is 
noteworthy that the non-homologous segments 
correspond to the region that represents an inser- 
tion in the mAChR as compared with the P- 
adrenergic receptor [20,21] and rhodopsin [22]; the 
structural homology among the three proteins has 
been discussed [7]. 
The cardiac mAChR shares characteristic struc- 
tural features with the cerebral mAChR [7]. The 
hydropathy profiles [23] of the two mAChRs are 
very similar (see [7]), suggesting the presence of 
seven hydrophobic segments (I-VII), which repre- 
sent putative transmembrane cu-helices; segment 
VII is less hydrophobic than the others. The only 
charged amino acid residues present in these 
segments are two aspartic acid residues (residue 69 
in segment II and residue 103 in segment III), 
which are conserved in the two mAChRs; the 
amino acid numbers refer to those of the cardiac 
mAChR. The cardiac mAChR, like the cerebral 
mAChR, lacks an amino-terminal signal sequence 
[24], and the amino-terminal region preceding seg- 
ment I contains potential N-glycosylation sites [25] 
(asparagine residues 2,3 and 6); N-glycosylation of 
residues 2 and 3 may be mutually exclusive. The 
carboxy-terminal region of the cardiac mAChR 
contains several potential sites of phosphorylation 
(threonine residues 446, 450 and 465), as is the case 
for the cerebral mAChR. These structural features 
are generally shared by rhodopsin [22,26] and the 
,Sadrenergic receptor [20,21,27]. Thus it is sug- 
gested that the cardiac mAChR, like the cerebral 
_iLNi___ 0 _--..__&-R__ 466 W)$KIPKRPGSVH~TPSR C % 460 _--
Fig.2. Alignment of the amino acid sequences of the porcine cardiac (top) and cerebral (bottom) mAChRs. The one- 
letter amino acid notation is used. The sequence data for the cerebral mAChR have been taken from [7]. Sets of identical 
residues are enclosed with solid lines, and sets of conservative residues with dashed lines; conservative substitutions are 
defined as pairs of residues belonging to one of the following groups: S, T, P, A and G; N, D, E and Q; H, R and 
K; M, I, L and V; F, Y and W [19]. Gaps (-) have been inserted to achieve maximum homology. The non-homologous 
segments are shown by lines together with the sum of residues present in each segment given in parentheses. The number 
of the residue at the right end of each line is given. The positions of the putative transmembrane segments I-VII are 
indicated; the termini of each segment are tentatively assigned [7]. The asparagine residues as potential N-glycosylation 
sites in the amino-terminal region are marked with asterisks. 
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mAChR, has a transmembrane topography similar 
to that of bacteriorhodopsin [28-301 and rhodop- 
sin [22,31,32]. 
In view of the different tissue locations of the 
mAChR subtypes [4-61, we examined poly(A)+ 
RNA from several porcine tissues for the species 
hybridizing with a cardiac mAChR cDNA probe 
(fig.3). The heart (lane 4) and medulla-pons (lane 
3), known to be representative sites for the Mz sub- 
type, contained a hybridizable RNA species of 
-6100 nucleotides. On the other hand, the 
cerebral cortex (lane 1) and corpus striatum (lane 
1 . ..’ 
Fig.3. Autoradiogram of blot hybridization analysis of 
poly(A)+ RNA from porcine cerebral cortex (lane l), 
corpus striatum (lane 2), medulla-pons (lane 3) and 
atrium (lane 4) using a cardiac mAChR cDNA probe. 
The procedures used were as described previously [7], 
except that the hybridization probe (spec. act. 2.4 x lo* 
cpm/pg) was the HinfI(337)-DdeI(813) fragment from 
clone pmACR423, labelled by nick-translation [15] with 
[cu-32P]dCTP; 15 Fg of each poly(A)+ RNA sample was 
used. Autoradiography was performed at - 70°C for 90 
h with an intensifying screen. The size markers were por- 
cine and E. coli rRNAs [33]. 
2), known to contain preferentially the Mr sub- 
type, contained only a small or hardly detectable 
amount of this RNA species. We have previously 
shown that the RNA species hybridizing with the 
cerebral mAChR cDNA is present selectively in the 
cerebral cortex and corpus striatum [7]. These 
results, taken together, suggest hat the cerebral 
and the cardiac mAChR cDNA we have cloned en- 
code the mAChRs of the Ml and the Mz subtype, 
respectively, implying that the mAChR subtypes 
represent distinct gene products. 
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